Pfizer officials announced the company will sell the Capsugel capsule-making business to private equity firm Kohlberg Kravis Roberts & Co. for $2.4 billion in cash.
Pfizer to sell capsule business for $2.4 billion
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You